Knowledge

Viridos (company)

Source đź“ť

681: 548:
Many of SGI's collaborations have been with energy companies. In 2007, SGI worked with BP to commercialize microbial-based processes for increasing the conversion and recovery of subsurface hydrocarbons. In 2009, SGI received funding from
682:"Synthetic Genomics Inc. Expands Collaborative Research and Development Agreement with Lung Biotechnology PBC, a Subsidiary of United Therapeutics Corporation, to Develop Organs for Transplantation" 695: 405:. In 2015, the company launched the BioXP 3200 system, a fully automated benchtop instrument that produces DNA fragments from many different sources for genomic data. 907: 968: 896: 157: 723: 885: 737: 165: 856: 918: 419:
SGI has a number of commercial as well as research and development stage programs across a variety of industries. Some of these
929: 272:, especially harnessing photosynthesis with micro algae to create alternatives to fossil fuels. Viridos designs and builds 757: 580:
In 2010, Synthetic Genomics spun off a new subsidiary, Synthetic Genomics Vaccines Inc., to develop next generation
963: 709: 382: 349:
to design and build biological systems. The company produces or performs research in the fields of sustainable
973: 978: 983: 577:
to Launch Gibson Assembly Master Mix Product for Synthetic and Molecular Biology Applications in 2012.
394: 346: 124: 872: 374: 470: 408:
The company's efforts in bio-based production are intended to improve both existing production
326: 146: 412:
and develop entirely new synthetic production hosts with the goal of more efficient routes to
587: 420: 402: 386: 358: 95: 87: 39: 534: 334: 322: 314: 298: 573:
for their collaboration with Exxon Mobil. They also signed a collaborative agreement with
8: 591: 574: 566: 445: 440: 354: 318: 119: 742: 538: 135: 109: 24: 828: 802: 561:
and other microorganisms. The company purchased an 81-acre site (33 ha) in the
542: 526: 302: 286: 269: 214: 20: 818: 788: 268:, California, changed its name to Viridos. The company is focused on the field of 823: 806: 696:"Novartis Teams with Synthetic Genomics Vaccines to Develop Flu Seed Virus Banks" 562: 530: 522: 306: 273: 209: 49: 480:
To provide nutritional oils that overcome cost barrier in multiple applications
845: 663: 465:
To stockpile synthetic flu vaccines for rapid response to global flu outbreaks
409: 398: 330: 280: 114: 19:
This article is about the company Synthetic Genomics. For the field related to
957: 765: 294: 181: 545:
related to the generation of organisms artificially using genetic material.
510:
To develop an algae platform that can produce economically viable biodiesel
832: 529:, Juan Enriquez, and David Kiernan. Venter (and Smith)'s previous company, 342: 338: 176: 490: 475: 413: 570: 550: 500: 310: 224: 738:"Exxon Sinks $ 600M Into Algae-Based Biofuels in Major Strategy Shift" 724:"Monsanto Acquires Parts of Agradis, Partners with Synthetic Genomics" 350: 946: 639: 495:
To map microbiome metagenome related to plant health and crop yield
581: 485: 460: 455: 390: 378: 362: 265: 91: 63: 615: 554: 505: 290: 859:
Craig Venter Has Algae Biofuel in Synthetic Genomics’ Pipeline.
664:"SGI-DNA Launches the BioXp™ 3200 System Early Access Program" 558: 277: 807:"Genomics. Synthetic genome brings new life to bacterium" 595: 450:
To reduce the risk of rejection in organ transplantation
247: 203: 521:
Synthetic Genomics was founded in the spring of 2005 by
381:
segment focuses on genomics solutions for academic and
710:"Synthetic Genomics and ADM partner for omega-3 DHA" 377:: research, bioproduction and applied products. The 533:, was a driving force in the race to sequence the 955: 594:valued at $ 50M and brought in Oliver Fetzer as 385:. The commercial products and services include 321:. Synthetic Genomics uses techniques such as 969:Biotechnology companies of the United States 786: 537:. The firm takes its name from the phrase 293:and engineering, combining fields such as 873:"Scientist on plan to turn algae to fuel" 822: 557:on an industrial-scale using recombinant 801: 586:In 2014 SGI expanded into the field of 956: 762:Synthetic Genomics' corporate website 590:with a collaborative agreement with 541:which is a scientific discipline of 357:, targeted medicines, DNA synthesis 789:"Venter revives synthetic bug talk" 13: 787:Whitehouse, David (July 4, 2005). 640:"Algal Genomics and Biotechnology" 361:as well as a number of biological 289:is an interdisciplinary branch of 232:Synthetic Genomics Vaccines (SGVI) 16:American synthetic biology company 14: 995: 938: 383:commercial research organizations 264:), a private company located in 923: 912: 901: 890: 879: 865: 850: 839: 795: 780: 368: 750: 730: 716: 702: 688: 674: 656: 632: 608: 1: 601: 373:SGI mainly operates in three 824:10.1126/science.328.5981.958 7: 10: 1000: 861:Xconomy San Diego. 6/4/09. 758:"About Synthetic Genomics" 516: 353:, insect resistant crops, 18: 499: 484: 469: 454: 439: 434: 431: 428: 242: 223: 193: 133: 102: 83: 73: 55: 45: 35: 857:Juha-Pekka Tikka : 162:David Kiernan, M.D., J.D 154:Reinhard J. Ambros, Ph.D 151:Oliver Fetzer, Ph.D, MBA 964:Algae biomass producers 258:Synthetic Genomics Inc. 186:Hamilton O. Smith. M.D. 137:Board of directors 147:J. Craig Venter, Ph.D. 930:Union Tribune Article 875:. NPR. July 15, 2009. 768:on September 24, 2005 588:organ transplantation 446:Organ Transplantation 421:research partnerships 355:transplantable organs 40:J. Craig Venter Ph.D. 335:analytical chemistry 323:software engineering 315:computer engineering 299:evolutionary biology 96:Bioinformatics Tools 974:Genetic engineering 592:United Therapeutics 575:New England Biolabs 567:Southern California 441:United Therapeutics 319:genetic engineering 256:In September 2021, 120:Plasmid preparation 32: 979:Genomics companies 743:The New York Times 539:synthetic genomics 274:biological systems 158:Juan Enriquez, MBA 30: 25:Synthetic genomics 984:Synthetic biology 817:(5981): 958–959. 698:. 7 October 2010. 543:synthetic biology 527:Hamilton O. Smith 525:, Nobel Laureate 514: 513: 456:Novartis Vaccines 303:molecular biology 287:Synthetic biology 270:synthetic biology 254: 253: 215:Hamilton O. Smith 21:synthetic biology 991: 950: 949: 947:Official website 932: 927: 921: 916: 910: 905: 899: 894: 888: 883: 877: 876: 869: 863: 854: 848: 843: 837: 836: 826: 799: 793: 792: 784: 778: 777: 775: 773: 764:. Archived from 754: 748: 747: 734: 728: 727: 720: 714: 713: 706: 700: 699: 692: 686: 685: 684:(Press release). 678: 672: 671: 660: 654: 653: 651: 650: 636: 630: 629: 627: 626: 616:"News and Media" 612: 426: 425: 333:, biodiscovery, 250: 173:Tina Nova, Ph.D. 138: 125:Custom Synthesis 110:Cell engineering 66: 33: 29: 999: 998: 994: 993: 992: 990: 989: 988: 954: 953: 945: 944: 941: 936: 935: 928: 924: 917: 913: 906: 902: 895: 891: 884: 880: 871: 870: 866: 855: 851: 844: 840: 800: 796: 785: 781: 771: 769: 756: 755: 751: 736: 735: 731: 722: 721: 717: 708: 707: 703: 694: 693: 689: 680: 679: 675: 662: 661: 657: 648: 646: 638: 637: 633: 624: 622: 614: 613: 609: 604: 563:Imperial Valley 531:Celera Genomics 523:J. Craig Venter 519: 387:instrumentation 371: 307:systems biology 248:www.viridos.com 246: 238: 219: 210:J. Craig Venter 202:Oliver Fetzer ( 196: 189: 140: 136: 129: 98: 94: 90: 76: 69: 62: 50:Private company 28: 17: 12: 11: 5: 997: 987: 986: 981: 976: 971: 966: 952: 951: 940: 939:External links 937: 934: 933: 922: 911: 900: 889: 878: 864: 849: 838: 794: 779: 749: 729: 715: 701: 687: 673: 655: 631: 606: 605: 603: 600: 518: 515: 512: 511: 508: 503: 497: 496: 493: 488: 482: 481: 478: 473: 467: 466: 463: 458: 452: 451: 448: 443: 437: 436: 433: 430: 399:bioinformatics 397:services, and 370: 367: 331:bioinformatics 281:sustainability 252: 251: 244: 240: 239: 237: 236: 233: 229: 227: 221: 220: 218: 217: 212: 207: 199: 197: 194: 191: 190: 188: 187: 184: 179: 174: 171: 168: 163: 160: 155: 152: 149: 143: 141: 134: 131: 130: 128: 127: 122: 117: 115:DNA sequencing 112: 106: 104: 100: 99: 85: 81: 80: 77: 74: 71: 70: 68: 67: 59: 57: 53: 52: 47: 43: 42: 37: 15: 9: 6: 4: 3: 2: 996: 985: 982: 980: 977: 975: 972: 970: 967: 965: 962: 961: 959: 948: 943: 942: 931: 926: 920: 915: 909: 908:Press Release 904: 898: 893: 887: 886:Press Release 882: 874: 868: 862: 860: 853: 847: 846:Press Release 842: 834: 830: 825: 820: 816: 812: 808: 804: 798: 790: 783: 767: 763: 759: 753: 745: 744: 739: 733: 725: 719: 711: 705: 697: 691: 683: 677: 669: 665: 659: 645: 641: 635: 621: 617: 611: 607: 599: 597: 593: 589: 584: 583: 578: 576: 572: 568: 564: 560: 556: 552: 546: 544: 540: 536: 532: 528: 524: 509: 507: 504: 502: 498: 494: 492: 489: 487: 483: 479: 477: 474: 472: 468: 464: 462: 459: 457: 453: 449: 447: 444: 442: 438: 427: 424: 422: 417: 415: 411: 406: 404: 401:services and 400: 396: 395:DNA synthesis 392: 388: 384: 380: 376: 366: 364: 360: 356: 352: 348: 347:DNA synthesis 344: 340: 336: 332: 328: 327:bioprocessing 324: 320: 316: 312: 308: 304: 300: 296: 295:biotechnology 292: 288: 284: 282: 279: 275: 271: 267: 263: 259: 249: 245: 241: 234: 231: 230: 228: 226: 222: 216: 213: 211: 208: 205: 201: 200: 198: 192: 185: 183: 182:Barry Schuler 180: 178: 175: 172: 170:William McKee 169: 167: 164: 161: 159: 156: 153: 150: 148: 145: 144: 142: 139: 132: 126: 123: 121: 118: 116: 113: 111: 108: 107: 105: 101: 97: 93: 89: 86: 82: 78: 72: 65: 61: 60: 58: 54: 51: 48: 44: 41: 38: 34: 26: 22: 925: 914: 903: 892: 881: 867: 858: 852: 841: 814: 810: 797: 782: 772:November 26, 770:. Retrieved 766:the original 761: 752: 741: 732: 718: 704: 690: 676: 667: 658: 647:. Retrieved 643: 634: 623:. Retrieved 619: 610: 585: 579: 547: 535:human genome 520: 418: 407: 372: 369:Core markets 343:optimization 339:fermentation 285: 261: 257: 255: 225:Subsidiaries 177:Alfonso Romo 166:Kok-Thay Lim 75:Area served 64:La Jolla, CA 803:Pennisi, E. 569:to produce 553:to produce 491:Agriculture 414:bioproducts 375:end markets 359:instruments 276:to address 235:Genovia Bio 88:Instruments 958:Categories 649:2022-05-23 625:2022-05-23 602:References 571:algae fuel 551:ExxonMobil 501:ExxonMobil 311:biophysics 283:problems. 195:Key people 506:Biodiesel 423:include: 351:bio-fuels 79:Worldwide 833:20488994 805:(2010). 582:vaccines 555:biofuels 486:Monsanto 476:Food Oil 461:Vaccines 429:Partner 403:software 391:reagents 379:research 363:reagents 266:La Jolla 103:Services 92:Reagents 84:Products 56:Location 919:Article 897:Article 811:Science 668:SGI-DNA 644:Viridos 620:Viridos 517:History 435:Target 341:, cell 291:biology 243:Website 36:Founder 31:Viridos 831:  791:. BBC. 432:Focus 345:, and 317:, and 278:global 23:, see 559:algae 410:hosts 829:PMID 774:2005 46:Type 819:doi 815:328 596:CEO 565:in 471:ADM 262:SGI 204:CEO 960:: 827:. 813:. 809:. 760:. 740:. 666:. 642:. 618:. 598:. 416:. 393:, 389:, 365:. 337:, 329:, 325:, 313:, 309:, 305:, 301:, 297:, 835:. 821:: 776:. 746:. 726:. 712:. 670:. 652:. 628:. 260:( 206:) 27:.

Index

synthetic biology
Synthetic genomics
J. Craig Venter Ph.D.
Private company
La Jolla, CA
Instruments
Reagents
Bioinformatics Tools
Cell engineering
DNA sequencing
Plasmid preparation
Custom Synthesis
Board of directors
J. Craig Venter, Ph.D.
Juan Enriquez, MBA
Kok-Thay Lim
Alfonso Romo
Barry Schuler
CEO
J. Craig Venter
Hamilton O. Smith
Subsidiaries
www.viridos.com
La Jolla
synthetic biology
biological systems
global
sustainability
Synthetic biology
biology

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑